GSK China’s bribery scandal resolved with heavy sentence

A few months ago, GlaxoSmithKline was shamefaced with its scandal in China, involving embezzlement of public property and bribery to then deputy health commission chief, Dr. Fengping Huang. A majority of hospitals in China are state-run and are financially, minimally supported by the government. To supplement their unsatisfactory income, doctors often accept a sum to prioritize patients who require expensive …

Prescription drugs on sale online in China

With China Food and Drug Administration (CFDA)’s recently introduced policy, the Chinese can now potentially purchase their prescription drugs online at Walmart or even Alibaba.com. Though the final list of available prescription drugs are to be consolidated over the next couple of days, this new policy seems to have sparked a discussion amongst China and the region. If prescription drugs, …

Bio-Printing Organs: China Moving in the Right Direction

Chinese scientists have announced a step forward in the field of regenerative medicine for their nation. Researchers from eastern china have revealed a 3D Bio-Printer which uses a biological gel as its building material, to create and form rudimentary organs and body parts, Reuters reports. With scandal surrounding Chinese institutions in charge of organ donation, allegedly demanding money from hospitals …

Discounts needed to access China pharma market

"If we can arrange an appropriate, acceptable, affordable price, then you can have a huge market," says China's top health official, Chen Zhu, who stepped down last month (Bloomberg). Health-care spending in China – now the world' third-largest pharmaceutical market – is expected to almost triple by 2020 to $1 trillion a year. However, if Western pharmaceutical companies want to …

Sanofi plans China growth with 4 new plants

Sanofi plans to open four manufacturing plants this year in China, reports the Wall Street Journal. The WSJ reports that Sanofi expects to see "double-digit sales growth" in the next five years in China, and plans to expand its animal health and vaccine business in the country. The French pharmaceutical company currently has six plants in China, but the addition …

Is China prepared for orphan drug development and access?

As the orphan drug market grows exponentially, everyone is looking into China and whether the country is prepared to provide access for therapies to rare disease patients. Pharma companies like Genzyme have made strong efforts to introduce one of its orphan drugs in China and into the healthcare system in force. China has reached a remarkable achievement in the past …

Whitepaper Download – Managing Clinical Trials and Central Laboratory Services in China, by PPD

China's huge population and growing commitment to health care are predicted to make the country the world's second-largest consumer of pharmaceuticals by 2015. However, despite the size of the market, the large numbers of treatment-naïve patients, and the necessity of collecting clinical trial data patients in China before the Chinese State Food and Drug Administration (SFDA) will approve a drug …